201 related articles for article (PubMed ID: 34839237)
1. Computational approaches to understanding Clostridioides difficile metabolism and virulence.
Jenior ML; Papin JA
Curr Opin Microbiol; 2022 Feb; 65():108-115. PubMed ID: 34839237
[TBL] [Abstract][Full Text] [Related]
2. Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in
Pensinger DA; Dobrila HA; Stevenson DM; Hryckowian ND; Amador-Noguez D; Hryckowian AJ
mBio; 2024 Mar; 15(3):e0253523. PubMed ID: 38289141
[TBL] [Abstract][Full Text] [Related]
3.
Cheng JKJ; Unnikrishnan M
Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
[No Abstract] [Full Text] [Related]
4.
Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R
mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404
[TBL] [Abstract][Full Text] [Related]
5. Microbe-microbe interactions during Clostridioides difficile infection.
Abbas A; Zackular JP
Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
[TBL] [Abstract][Full Text] [Related]
6. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
7. Negative interactions determine Clostridioides difficile growth in synthetic human gut communities.
Hromada S; Qian Y; Jacobson TB; Clark RL; Watson L; Safdar N; Amador-Noguez D; Venturelli OS
Mol Syst Biol; 2021 Oct; 17(10):e10355. PubMed ID: 34693621
[TBL] [Abstract][Full Text] [Related]
8. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
9. Gut Microbiota Diversity of Preterm Neonates Is Associated With
Couturier J; Lepage P; Jolivet S; Delannoy J; Mesa V; Ancel PY; Rozé JC; Butel MJ; Barbut F; Aires J
Front Cell Infect Microbiol; 2022; 12():907323. PubMed ID: 35873148
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics investigation of
Fishbein SR; Robinson JI; Hink T; Reske KA; Newcomer EP; Burnham CD; Henderson JP; Dubberke ER; Dantas G
Elife; 2022 Jan; 11():. PubMed ID: 35083969
[No Abstract] [Full Text] [Related]
11. Pathogenicity and virulence of
Buddle JE; Fagan RP
Virulence; 2023 Dec; 14(1):2150452. PubMed ID: 36419222
[No Abstract] [Full Text] [Related]
12. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
13. In vivo commensal control of Clostridioides difficile virulence.
Girinathan BP; DiBenedetto N; Worley JN; Peltier J; Arrieta-Ortiz ML; Immanuel SRC; Lavin R; Delaney ML; Cummins CK; Hoffman M; Luo Y; Gonzalez-Escalona N; Allard M; Onderdonk AB; Gerber GK; Sonenshein AL; Baliga NS; Dupuy B; Bry L
Cell Host Microbe; 2021 Nov; 29(11):1693-1708.e7. PubMed ID: 34637781
[TBL] [Abstract][Full Text] [Related]
14. A short chain fatty acid-centric view of Clostridioides difficile pathogenesis.
Gregory AL; Pensinger DA; Hryckowian AJ
PLoS Pathog; 2021 Oct; 17(10):e1009959. PubMed ID: 34673840
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota interspecies interactions shape the response of Clostridioides difficile to clinically relevant antibiotics.
Hromada S; Venturelli OS
PLoS Biol; 2023 May; 21(5):e3002100. PubMed ID: 37167201
[TBL] [Abstract][Full Text] [Related]
16. The Stickland Reaction Precursor
Reed AD; Fletcher JR; Huang YY; Thanissery R; Rivera AJ; Parsons RJ; Stewart AK; Kountz DJ; Shen A; Balskus EP; Theriot CM
mSphere; 2022 Apr; 7(2):e0092621. PubMed ID: 35350846
[TBL] [Abstract][Full Text] [Related]
17. Capturing the environment of the Clostridioides difficile infection cycle.
Schnizlein MK; Young VB
Nat Rev Gastroenterol Hepatol; 2022 Aug; 19(8):508-520. PubMed ID: 35468953
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
19. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
20. Acquisition site-based remodelling of Clostridium perfringens- and Clostridioides difficile-related gut microbiota.
Herrera G; Vega L; Camargo A; Patarroyo MA; Ramírez JD; Muñoz M
Comp Immunol Microbiol Infect Dis; 2023 Nov; 102():102074. PubMed ID: 37832162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
